Company / Working Capital
Cencora Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$5.6B
FY2025
5-year range
-$6.6B / -$2.6B
FY2021-FY2025
Trend
+14.9%
vs FY2024
Sector context
#156 of 160
Health Care
What the data says
Among 160 Health Care companies, Cencora is in the bottom 3% for working capital. Working Capital returned to growth in FY2025 after 4 years of decline, reaching -$5.6B.
Based on SEC 10-K filings.
-$5.6B in FY2025.
Improved from -$6.0B to -$5.6B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 160This company -$5.6B Sector average $757.1M
▼
-837.3% below sector average
Key checks
Key Insights
- In FY2025, working capital increased 14.9% year-over-year.
- Ranks #156 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2020.
- Lowest working capital in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.32 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.6B | +14.9% |
| FY2024 | -$6.6B | -8.7% |
| FY2023 | -$6.0B | -55.1% |
| FY2022 | -$3.9B | -52.1% |
| FY2021 | -$2.6B | -220.6% |
| FY2020 | -$797.4M | +45.0% |
| FY2019 | -$1.4B | +26.6% |
| FY2018 | -$2.0B | +21.5% |
| FY2017 | -$2.5B | -3.6% |
| FY2016 | -$2.4B | -2.6% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026